Survey: Genetic Testing for Prostate Cancer - Delphi Panel
Members are invited to participate in an online survey on genetic testing for prostate cancer. This survey is part of a Delphi study that aims to measure consensus among Australian clinicians, researchers, healthcare providers and consumers about prostate cancer genetic testing recommendations reported in current international guidelines.
Please read the Participant Information Sheet for more details. In short, you will be asked to complete two or three rounds of an online survey. In each round, you will be asked to state your level of agreement with genetic testing recommendations for the Australian setting.
Each survey round will start on a specified date, be open for two weeks and should take about 15 minutes to complete. The first round will commence on February 17 and close at 11.59pm March 3.
If you consent to participate, access the survey: Genetic Testing for Prostate Cancer study.